Anton Stuetz

2.1k total citations
35 papers, 1.5k citations indexed

About

Anton Stuetz is a scholar working on Dermatology, Immunology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Anton Stuetz has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 12 papers in Immunology and 7 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Anton Stuetz's work include Dermatology and Skin Diseases (16 papers), Fungal Plant Pathogen Control (6 papers) and Contact Dermatitis and Allergies (5 papers). Anton Stuetz is often cited by papers focused on Dermatology and Skin Diseases (16 papers), Fungal Plant Pathogen Control (6 papers) and Contact Dermatitis and Allergies (5 papers). Anton Stuetz collaborates with scholars based in Austria, Switzerland and Germany. Anton Stuetz's co-authors include Josef G. Meingassner, Gabor Petrányi, Andreas Billich, Maximilian A. Grassberger, Heinrich Aschauer, Klaus Wolff, András Aszódi, Georg Stingl, Peter Nußbaumer and Ingrid Leitner and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Anton Stuetz

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anton Stuetz Austria	23	690	335	328	289	242	35	1.5k
M. Grundmann-Kollmann Germany	18	534 0.8×	128 0.4×	290 0.9×	134 0.5×	32 0.1×	27	989
Mutsuhiko Minami Japan	22	140 0.2×	106 0.3×	537 1.6×	630 2.2×	117 0.5×	51	1.5k
Milton Kern United States	21	145 0.2×	101 0.3×	444 1.4×	580 2.0×	105 0.4×	59	1.5k
Jiong Li China	22	99 0.1×	38 0.1×	474 1.4×	725 2.5×	47 0.2×	62	1.4k
Denis Thiolat France	16	112 0.2×	19 0.1×	343 1.0×	332 1.1×	336 1.4×	19	1.3k
Haoming Xu China	12	112 0.2×	53 0.2×	137 0.4×	823 2.8×	200 0.8×	26	1.3k
Mats Strömqvist Sweden	19	56 0.1×	73 0.2×	52 0.2×	431 1.5×	39 0.2×	37	1.1k
Sandeep Kumar United States	22	52 0.1×	55 0.2×	322 1.0×	767 2.7×	49 0.2×	62	1.6k
Gurpreet S. Ahluwalia United States	21	289 0.4×	14 0.0×	78 0.2×	780 2.7×	107 0.4×	48	1.7k
Jia Zhou China	19	69 0.1×	45 0.1×	187 0.6×	319 1.1×	23 0.1×	61	921

Countries citing papers authored by Anton Stuetz

Since Specialization

Citations

This map shows the geographic impact of Anton Stuetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Stuetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Stuetz more than expected).

Fields of papers citing papers by Anton Stuetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Stuetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Stuetz. The network helps show where Anton Stuetz may publish in the future.

Co-authorship network of co-authors of Anton Stuetz

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Stuetz. A scholar is included among the top collaborators of Anton Stuetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Stuetz. Anton Stuetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baumann, Karl, et al.. (2011). Chemistry of the Immunomodulatory Macrolide Ascomycin and Related Analogues. Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products. 94. 59–126. 9 indexed citations

Ahrens, Kerstin, Michael Schunck, Josef G. Meingassner, et al.. (2010). Mechanical and Metabolic Injury to the Skin Barrier Leads to Increased Expression of Murine β-Defensin-1, -3, and -14. Journal of Investigative Dermatology. 131(2). 443–452. 48 indexed citations

Halin, Cornelia, Josef G. Meingassner, Guido Bold, et al.. (2008). Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor. American Journal Of Pathology. 173(1). 265–277. 72 indexed citations

Weiss, H., et al.. (2008). Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application. Drug Metabolism and Disposition. 36(9). 1812–1818. 35 indexed citations

Winiski, Anthony P., et al.. (2007). Inhibition of T‐cell activation in vitro in human peripheral blood mononuclear cells by pimecrolimus and glucocorticosteroids and combinations thereof. Experimental Dermatology. 16(8). 699–704. 8 indexed citations

Billich, Andreas, et al.. (2005). Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight. Bioorganic & Medicinal Chemistry. 13(9). 3157–3167. 23 indexed citations

Krummen, Mathias, Georg Varga, Meike Steinert, et al.. (2005). Effect of pimecrolimus vs. corticosteroids on murine bone marrow‐derived dendritic cell differentiation, maturation and function. Experimental Dermatology. 15(1). 43–50. 13 indexed citations

Nell, Barbara, et al.. (2004). Exploratory Study Reveals Topical Pimecrolimus Is Active Against Keratoconjunctivitis Sicca And Chronic Superficial Keratitis In Dogs.. Investigative Ophthalmology & Visual Science. 45(13). 131–131. 2 indexed citations

Hoetzenecker, Wolfram, Josef G. Meingassner, Rupert Ecker, et al.. (2004). Corticosteroids But Not Pimecrolimus Affect Viability, Maturation and Immune Function of Murine Epidermal Langerhans Cells. Journal of Investigative Dermatology. 122(3). 673–684. 91 indexed citations

10.

Wolff, Klaus & Anton Stuetz. (2004). Pimecrolimus for the treatment of inflammatory skin disease. Expert Opinion on Pharmacotherapy. 5(3). 643–655. 45 indexed citations

11.

Billich, Andreas, Heinrich Aschauer, András Aszódi, & Anton Stuetz. (2003). Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. International Journal of Pharmaceutics. 269(1). 29–35. 141 indexed citations

12.

Kalthoff, Frank, et al.. (2002). Pimecrolimus inhibits up-regulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogeneic dendritic cells. Clinical & Experimental Immunology. 130(1). 85–92. 25 indexed citations

13.

Rappersberger, Klemens, Michael Komar, Klaus Wolff, et al.. (2002). Pimecrolimus Identifies a Common Genomic Anti-inflammatory Profile, is Clinically Highly Effective in Psoriasis and is Well Tolerated. Journal of Investigative Dermatology. 119(4). 876–887. 88 indexed citations

14.

Schuster, Inge, et al.. (2001). Selective inhibition of vitamin D hydroxylases in human keratinocytes11Abbreviations: VD: vitamin D3; 25(OH)D3: 25-hydroxyvitamin D3; 3H-25(OH)D3: [26,27n-3H] 25-hydroxyvitamin D3; 1α,25(OH)2D3: 1α,25-dihydroxyvitamin D3; 1α,25(OH)2-3epi-D3: 1α,25-dihydroxyvitamin-3-epi-D3; 1α,24(R),25(OH)3D3: 1α,24(R),25-trihydroxyvitamin D3, 1α,25(OH)2-24oxo-D3: 1α,25-dihydroxy-24oxo-vitamin D3; 1α,23(S),25(OH)3-24oxo-D3: 1α,23(S),25-trihydroxy-24oxo-vitamin D3; calcitroic acid: 1α-hydroxy-23-carboxy-24,25,26,27-tetranorvitamin D3; CYP: cytochrome P450; 1α-hydroxylase: 25-hydroxyvitamin D3-1α-hydroxylase; 24-hydroxylase (CYP24), 1α,25-hydroxyvitamin D3-24-hydroxylase; PHK, primary human keratinocytes; KGM: keratinocyte growth medium; HPLC, high performance liquid chromatography; IC50: half-maximum inhibitor concentration; SD: standard deviation.. Steroids. 66(3-5). 409–422. 57 indexed citations

15.

Stuetz, Anton, Maximilian A. Grassberger, & Josef G. Meingassner. (2001). Pimecrolimus (Elidel, SDZ ASM 981)—Preclinical pharmacologic profile and skin selectivity. Seminars in Cutaneous Medicine and Surgery. 20(4). 233–241. 99 indexed citations

16.

Paul, C., Michael Graeber, & Anton Stuetz. (2000). Ascomycins: promising agents for the treatment of inflammatory skin diseases. Expert Opinion on Investigational Drugs. 9(1). 69–77. 52 indexed citations

17.

Nußbaumer, Peter, et al.. (1995). Synthesis and Structure-Activity Relationships of Side-Chain-Substituted Analogs of the Allylamine Antimycotic Terbinafine Lacking the Central Amino Function. Journal of Medicinal Chemistry. 38(10). 1831–1836. 93 indexed citations

18.

Nußbaumer, Peter, Anthony P. Winiski, Salvatore Cammisuli, et al.. (1994). Novel Antiproliferative Agents Derived from Lavendustin A. Journal of Medicinal Chemistry. 37(24). 4079–4084. 22 indexed citations

19.

Nußbaumer, Peter, Maximilian A. Grassberger, Ingrid Leitner, et al.. (1993). Synthesis and structure-activity relationships of phenyl-substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment. Journal of Medicinal Chemistry. 36(15). 2115–2120. 30 indexed citations

20.

Stuetz, Anton. (1993). ChemInform Abstract: The Discovery and Chemistry of Terbinafine. ChemInform. 24(43). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact